Bill > A09406

This bill regulates the sale of methamphetamine precursor drugs, specifically those containing ephedrine or pseudoephedrine, by establishing strict purchasing and sales requirements. The legislation mandates that retailers can only sell up to 3.6 grams per day or 9 grams per 30-day period of these substances, and must keep such products behind a checkout counter or in a locked case. Sellers must require photo identification from purchasers, record detailed transaction information in an electronic or paper logbook, and submit this information to a real-time stop sale system administered by state police. The bill requires an electronic tracking system that can generate stop sale alerts if purchase limits would be exceeded, with an override function for cases of potential imminent bodily harm. Violations are classified as a class A misdemeanor punishable by fine, and businesses can face civil penalties between $250 and $1,000 per violation. The law provides some protections for business owners if they have implemented employee training programs and did not knowingly participate in violations. Notably, the bill preempts all local ordinances regarding the sale of these substances and does not apply to prescription medications or drugs certified by the state pharmacy board as manufactured to prevent methamphetamine production.

Business and Industry

https://www.nysenate.gov/legislation/bills/2025/A9406